Analysts Set MedEquities Realty Trust Inc. (MRT) Price Target at $12.86

Shares of MedEquities Realty Trust Inc. (NYSE:MRT) have been given an average rating of “Hold” by the seven research firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $13.00.

MRT has been the topic of several analyst reports. Zacks Investment Research upgraded shares of MedEquities Realty Trust from a “sell” rating to a “hold” rating in a research note on Wednesday, July 19th. KeyCorp restated a “buy” rating and issued a $13.00 price target on shares of MedEquities Realty Trust in a research note on Friday, August 25th. Cantor Fitzgerald initiated coverage on shares of MedEquities Realty Trust in a research note on Thursday, August 31st. They issued an “overweight” rating and a $14.00 price target on the stock. Finally, Capital One Financial Corporation initiated coverage on shares of MedEquities Realty Trust in a research note on Monday. They issued an “equal weight” rating and a $13.00 price target on the stock.

Shares of MedEquities Realty Trust (NYSE:MRT) remained flat at $11.60 during midday trading on Friday. 110,722 shares of the company were exchanged. MedEquities Realty Trust has a 12-month low of $10.28 and a 12-month high of $13.06. The firm’s 50-day moving average is $11.67 and its 200 day moving average is $11.90. The stock has a market capitalization of $368.36 million and a P/E ratio of 35.26.

Several hedge funds and other institutional investors have recently bought and sold shares of MRT. UBS Group AG increased its stake in shares of MedEquities Realty Trust by 190.0% during the first quarter. UBS Group AG now owns 13,504 shares of the financial services provider’s stock valued at $151,000 after acquiring an additional 8,847 shares during the period. Eqis Capital Management Inc. acquired a new position in shares of MedEquities Realty Trust during the second quarter valued at approximately $153,000. Raymond James Financial Services Advisors Inc. acquired a new position in shares of MedEquities Realty Trust during the second quarter valued at approximately $154,000. Acadian Asset Management LLC acquired a new position in shares of MedEquities Realty Trust during the second quarter valued at approximately $175,000. Finally, Alliancebernstein L.P. acquired a new position in shares of MedEquities Realty Trust during the second quarter valued at approximately $175,000. Institutional investors and hedge funds own 93.17% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Analysts Set MedEquities Realty Trust Inc. (MRT) Price Target at $12.86” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/10/27/analysts-set-medequities-realty-trust-inc-mrt-price-target-at-12-86.html.

About MedEquities Realty Trust

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply